Janssen to Halt Tylenol Production

Source: PharmaManufacturing.com

May 06, 2013

Korea Times

Janssen Korea may be ordered to suspend the production of two types of Tylenol syrup for children after the authorities found that the Korean unit of the U.S.-based drug maker violated pertinent regulations.

The scope of punishment could also be expanded, depending on the outcome of an ongoing special investigation. The two drugs account for 16 percent of the local market, amounting to 21.4 billion won in sales. Read the full story.
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments